Breyanzi approved for certain types of large B-cell lymphoma
Biomaterials could mean better vaccines, virus-fighting surfaces
9 February 2021Medication errors: Cut your risk with these tips
9 February 2021Breyanzi approved for certain types of large B-cell lymphoma
Cell-based gene therapy Breyanzi (lisocabtagene maraleucel) has been approved to treat adults with certain types of large B-cell lymphoma who have not responded to other systemic treatment, the U.S. Food and Drug Administration announced Friday.
